Adams Diversified Equity Fund’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Adams Diversified Equity Fund’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-50,100	Closed	-$899K	–	230
2017 Q4	$899K	Sell	50,100 -14,700	-23%	-$181K	0.05%	102
2017 Q3	$765K	Sell	64,800 -2,300	-3%	-$25.8K	0.04%	192
2017 Q2	$705K	Buy	67,100 +13,700	+26%	+$140K	0.04%	189
2017 Q1	$587K	Buy	53,400 +1,500	+3%	+$17.4K	0.03%	207
2016 Q4	$703K	Buy	+51,900	New	+$724K	0.04%	198

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Adams Diversified Equity Fund's SCMP Position: Q1 2018 in Review

Adams Diversified Equity Fund sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 50,100 shares — an estimated $899K sold.

Adams Diversified Equity Fund first reported a position in SCMP in Q4 2016 and held it in 5 quarters. The position peaked at $899K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Adams Diversified Equity Fund reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Adams Diversified Equity Fund sold 50,100 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $899K.
Adams Diversified Equity Fund first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2016 and held it in 5 quarters.
Adams Diversified Equity Fund's Sucampo Pharmaceuticals, Inc. position peaked at $899K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Adams Diversified Equity Fund's 13F filing for Q1 2018, filed 27 Apr 2018.